[Infection in obstetrical and gynecologic surgery].
Explore the source record for details and available documents.
SEARCH · PubMed Health
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The author studied in 311 women long-term results of treatment of giant hernias, that were caused by urgent (52.4%) and planned (47.6%) obstetric and gynecologic operations. The original lavsan prostheses were used to cover the suprapubic abdominal wall defects that provided good long-term results with no cases of relapses, good functional and cosmetic effects, and complete restoration of capacity for work.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Twelve years experience with 6,000 incisions carried out in the Tertre Rouge clinic in Le Mans and 1,545 cases published by other authors demonstrate that the suprapubic transverse incision with section of the recti abdominis muscle is becoming more popular for pelvic surgery. The technique of the operation and its variations according to different authorities in different countries are fully described. There is also a review of the indications for the procedure, to show how it can be used for caesarean section especially when carried out under epidural anaesthesia. Finally, the incision is compared with those more usually used.
The goals of antibacterial prophylaxis during obstetric/gynaecological surgery are similar to those of prophylaxis during intra-abdominal surgery. The vaginal flora consists of many aerobic and anaerobic organisms, is dominated by peroxide-producing lactobacilli, and is non-pathogenic under normal conditions. Destabilization of the vaginal ecosystem, as in bacterial vaginosis (BV), causes a massive increase in the ratio of anaerobes to aerobes and is associated with a large increase in the risk of infection. The surgical procedures at most risk of postoperative infection are vaginal, abdominal and radical hysterectomy and caesarean section. Both the American College of Obstetricians and Gynecologists and the American Society of Health-System Pharmacists have recommended single-dose prophylactic protocols using a variety of agents (penicillins, cephalosporins and clindamycin). However, it remains doubtful whether prophylaxis is used widely. In Italy, such prophylaxis has proved less effective in women with BV. Accordingly, patients with confirmed BV are given topical clindamycin for 7 days leading up to surgery, in addition to the usual prophylactic regimen. Caesarean delivery carries a 5- to 20-fold greater risk of infection that normal vaginal delivery. A meta-analysis of 66 clinical studies has shown that any prophylactic regimen is effective in reducing postoperative complications. The use of prophylaxis in patients undergoing a low-risk caesarean section remain controversial.
OBJECTIVE: Vesicovaginal fistula resulting from prolonged obstructed labor remains a major problem in developing countries where medical care is limited. For many years surgical closure of the fistula was almost impossible. However, closure rates today range between 65% and 95%. Attention now is being focused on training more surgeons to repair simple fistulas, identifying and preventing complications that occur even with successful vesicovaginal fistula closure, developing new techniques to close the most difficult fistulas to repair, and working to improve obstetric care to prevent future vesicovaginal fistulas. This study reviews contemporary efforts to manage vesicovaginal fistulas with these goals in mind. STUDY DESIGN: One hundred consecutive vesicovaginal fistula repair operations that I performed in 82 patients are reviewed. Specific repair techniques are described for each vesicovaginal fistula type by anatomic vesicovaginal fistula classification. Primary closure rates and complications are examined by vesicovaginal fistula type, location, size, and number of prior repair attempts. RESULTS: After 100 operations, 78 of the 82 patients (95%) had successful vesicovaginal fistula closure. Primary closure rates were noted to be 31 of 33 (94%) for suburethral fistulas, 10 of 14 (71%) for midvaginal fistulas, 9 of 10 (90%) for juxta-cervical fistulas, 10 of 12 (83%) for urethral fistulas, 6 of 6 (100%) for uterovesical fistulas, but only 4 of 7 (57%) for combined vesicovaginal and rectovaginal fistulas. Repairs were only 50% successful on second attempts and only 33% successful on third attempts. Even in those patients who had successful closure of the fistula, serious complications occurred in 59% of patients, including other types of urinary incontinence, gynatresia, amenorrhea, and leg weakness. CONCLUSION: Basic principles of fistula surgery remain important in all types of vesicovaginal fistula repairs. Further research is needed into prevention and management of associated complications, into innovative repair of those few patients who do not have successful closure, and into training more surgeons to address the vesicovaginal fistula problem.
Explore the source record for details and available documents.
Explore the source record for details and available documents.